These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11447204)
1. Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice. Radcliff FJ; Ferrero RL Infect Immun; 2001 Aug; 69(8):5186-8. PubMed ID: 11447204 [TBL] [Abstract][Full Text] [Related]
2. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Shi T; Liu WZ; Gao F; Shi GY; Xiao SD Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen. Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Malfertheiner P; Schultze V; Rosenkranz B; Kaufmann SH; Ulrichs T; Novicki D; Norelli F; Contorni M; Peppoloni S; Berti D; Tornese D; Ganju J; Palla E; Rappuoli R; Scharschmidt BF; Del Giudice G Gastroenterology; 2008 Sep; 135(3):787-95. PubMed ID: 18619971 [TBL] [Abstract][Full Text] [Related]
5. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells. Raghavan S; Suri-Payer E; Holmgren J Scand J Immunol; 2004; 60(1-2):82-8. PubMed ID: 15238076 [TBL] [Abstract][Full Text] [Related]
6. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. Gottwein JM; Blanchard TG; Targoni OS; Eisenberg JC; Zagorski BM; Redline RW; Nedrud JG; Tary-Lehmann M; Lehmann PV; Czinn SJ J Infect Dis; 2001 Aug; 184(3):308-14. PubMed ID: 11443556 [TBL] [Abstract][Full Text] [Related]
7. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice. Nyström-Asklin J; Adamsson J; Harandi AM Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617 [TBL] [Abstract][Full Text] [Related]
8. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori antibodies and gastric cancer: a gender-related difference. Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Percival Andersen L; Wadström T FEMS Immunol Med Microbiol; 2005 May; 44(2):191-5. PubMed ID: 15866215 [TBL] [Abstract][Full Text] [Related]
10. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680 [TBL] [Abstract][Full Text] [Related]
11. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice. Matsumoto Y; Blanchard TG; Drakes ML; Basu M; Redline RW; Levine AD; Czinn SJ Helicobacter; 2005 Oct; 10(5):407-15. PubMed ID: 16181351 [TBL] [Abstract][Full Text] [Related]
12. Antibody response to Helicobacter pylori excretory antigen and the cross reaction study. Sasidharan S; Uyub AM J Immunoassay Immunochem; 2009; 30(1):70-81. PubMed ID: 19117203 [TBL] [Abstract][Full Text] [Related]
13. Recombinant Mycobacterium smegmatis mc(2)155 vaccine expressing outer membrane protein 26 kDa antigen affords therapeutic protection against Helicobacter pylori infection. Lü L; Cao HD; Zeng HQ; Wang PL; Wang LJ; Liu SN; Xiang TX Vaccine; 2009 Feb; 27(7):972-8. PubMed ID: 19111590 [TBL] [Abstract][Full Text] [Related]
14. Interaction of Helicobacter pylori-induced follicular gastritis and autoimmune gastritis in BALB/c mice with post-thymectomy autoimmune gastritis. Okazaki K; Ohana M; Oshima C; Uchida K; Nishi T; Iwano M; Fukui T; Kawasaki K; Matsuura M; Asada M; Tamaki H; Hiai H; Chiba T J Gastroenterol; 2003; 38(12):1131-7. PubMed ID: 14714249 [TBL] [Abstract][Full Text] [Related]
15. Antralization of gastric incisura is topographically associated with increased gastric epithelial apoptosis and proliferation, but not with CagA seropositivity. Xia HH; Wong BC; Zhang GS; Yang Y; Wyatt JM; Adams S; Cheung K; Lam SK; Talley NJ J Gastroenterol Hepatol; 2004 Nov; 19(11):1257-63. PubMed ID: 15482532 [TBL] [Abstract][Full Text] [Related]
16. The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori. Cooke CL; Huff JL; Solnick JV FEMS Immunol Med Microbiol; 2005 Jul; 45(1):11-23. PubMed ID: 15949928 [TBL] [Abstract][Full Text] [Related]
17. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020 [TBL] [Abstract][Full Text] [Related]
19. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine. Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394 [TBL] [Abstract][Full Text] [Related]
20. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori. Chui SY; Clay TM; Lyerly HK; Morse MA Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1883-9. PubMed ID: 16103431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]